Covid 19: FDA approves first herbal medicine for clinical trial

The Food and Drugs Authority has approved,  the National Medicine Regulatory Agency has announced the approval of the first herbal medicine for clinical trial on Covid 19 treatment .

This follows results from laboratory studies conducted by the Kwame Nkrumah University of Science and Technology KNUST research team which points in the direction of possible clinical benefits.

This means the medicine “Cryptolepis Sanguinolenta” locally known as Nibima if successfully approved could be use for the treatment of Covid 19 in the country.

A statement released by the Food and Drugs Authority said the authority remains committed to protect the health and safety of consumers.

Below is the full statement

https://asaaseradio.com/wp-content/uploads/2021/02/PRESS-RELEASE-FDA-APPROVES-FIRST-HERBAL-MEDICINE-FOR-CLINICAL-TRIAL-FOR-COVID-19-TREATMENT.pdf

Case Update 

 Fifteen (15) more COVID-19 related deaths have been recorded in Ghana taking the country’s death toll to 405 from 390 the Ghana Health Service reports.

The country has also recorded  797 new infections  pushing the active case count to 4,665.

So far the country has recorded a total of 65,427 confirmed cases with 60,357 people recovering or discharged.

Currently, Ghana has 125 and 44 persons in severe and critical conditions respectively.

Fred Dzakpata 

Gh Extractives

Ghextractives.com is an independent multimedia portal that seeks to provide credible information and news content to readers especially players in the extractive sector in Ghana, Africa and beyond. It also provides a unique platform for players in the energy sector to market their products and reach a wider audience

View All Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.